{"product_id":"xalkori-or-crizalk","title":"Xalkori or Crizalk","description":"\n\u003ch4\u003eXalkori (Crizotinib) - Comprehensive Product Description\u003c\/h4\u003e\n\u003cp\u003eXalkori, known generically as Crizotinib, is an oral medication used primarily for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). It is a targeted therapy that works by inhibiting the activity of ALK, thereby blocking the growth and spread of cancer cells.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003eXalkori is indicated for the treatment of adults with:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eALK-positive metastatic NSCLC\u003c\/li\u003e\n    \u003cli\u003eROS1-positive metastatic NSCLC\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eThe recommended dosage of Xalkori is \u003cstrong\u003e250 mg\u003c\/strong\u003e taken orally twice daily. It can be taken with or without food. Patients should swallow the capsules whole and not chew, crush, or open them.\u003c\/p\u003e\n\n\u003ch4\u003eMechanism of Action\u003c\/h4\u003e\n\u003cp\u003eCrizotinib is a small molecule inhibitor that selectively targets ALK and ROS1, two proteins involved in the growth of cancer cells. By inhibiting these proteins, Xalkori effectively disrupts the signaling pathways that promote tumor growth and survival.\u003c\/p\u003e\n\n\u003ch4\u003eSide Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects associated with Xalkori include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eNausea\u003c\/li\u003e\n    \u003cli\u003eDiarrhea\u003c\/li\u003e\n    \u003cli\u003eFatigue\u003c\/li\u003e\n    \u003cli\u003eVision changes\u003c\/li\u003e\n    \u003cli\u003eConstipation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSerious side effects may include liver problems, interstitial lung disease, and severe allergic reactions. Regular monitoring by a healthcare professional is recommended.\u003c\/p\u003e\n\n\u003ch4\u003eDrug Interactions\u003c\/h4\u003e\n\u003cp\u003eXalkori may interact with various medications, including:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eCYP3A inhibitors and inducers\u003c\/li\u003e\n    \u003cli\u003eAntiepileptic drugs\u003c\/li\u003e\n    \u003cli\u003eAntifungal medications\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePatients should inform their healthcare provider of all medications they are taking to avoid potential interactions.\u003c\/p\u003e\n\n\u003ch4\u003eStorage\u003c\/h4\u003e\n\u003cp\u003eStore Xalkori at room temperature, away from moisture and heat. Keep it out of reach of children.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eXalkori represents a significant advancement in the targeted treatment of ALK-positive NSCLC. Patients should consult their healthcare provider for more information and to determine if Xalkori is the right treatment option for their specific condition.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"200mg","offer_id":51735728783643,"sku":"Crizalk-200mg","price":3220.0,"currency_code":"USD","in_stock":true},{"title":"250mg","offer_id":51735728816411,"sku":"Crizalk-250mg","price":3350.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/untitled_design_-_2025-07-18t220319.915.png?v=1770407803","url":"https:\/\/ezchemist.com\/products\/xalkori-or-crizalk","provider":"EZ Chemist","version":"1.0","type":"link"}